Dynavax Technologies
DVAX
#5123
Rank
S$2.35 B
Marketcap
S$20.07
Share price
0.00%
Change (1 day)
12.57%
Change (1 year)

Dynavax Technologies (DVAX) - Total debt

Total debt on the balance sheet as of September 2025 : S$0.36 Billion

According to Dynavax Technologies 's latest financial reports the company's total debt is S$0.36 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

Dynavax Technologies - Total debt on balance sheet (from 2009 to 2025)

Total debt by year

Year Total debt Change
2024-12-31S$0.34 B1.92%
2023-12-31S$0.33 B-1.9%
2022-12-31S$0.34 B-0.6%
2021-12-31S$0.34 B20.74%
2020-12-31S$0.28 B-1.24%
2019-12-31S$0.29 B111.75%
2018-12-31S$0.13 B
2014-12-31S$12.63 M
2012-12-31N/A-100%
2011-12-31S$16.58 M9.31%
2010-12-31S$15.17 M-12.69%
2009-12-31S$17.38 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Pfizer
PFE
S$82.53 B 22,259.52%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
S$74.23 B 20,011.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
S$8.49 B 2,202.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
S$28.71 B 7,679.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
S$63.60 B 17,132.58%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
S$43.92 B 11,800.05%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
S$32.68 B 8,754.13%๐Ÿ‡ฌ๐Ÿ‡ง UK
Agenus
AGEN
S$59.27 M-83.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
S$21.89 B 5,831.78%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel